Haematological Cancers in African Children: Progress and Challenges

Simple item page
dc.contributor.authorMolyneux, E.
dc.contributor.authorScanlan, T.
dc.contributor.authorChagaluka, G.
dc.contributor.authorRenner, L.
dc.date.accessioned2019-08-14T15:55:33Z
dc.date.available2019-08-14T15:55:33Z
dc.date.issued2017-06
dc.description.abstractCancer is increasingly important in low and middle-income settings where infectious diseases are declining. Childhood cancers treated in well-resourced centres have excellent outcomes with more than 80% survival. This success is not reflected in low-income settings where challenges involve every step on the care pathway. Access to diagnosis, delayed presentation, advanced disease, co-morbidities and underlying malnutrition make treatment difficult. Treatments are costly for impoverished families. Yet, the common haematological malignancies (Burkitt lymphoma, Hodgkin lymphoma, non Hodgkin lymphoma) are relatively easy to diagnose and, when managed with simple chemotherapy protocols, give limited but good results. As funding becomes available for cancer research we must ensure that the care and cure of these children is top of the agenda. There is already evidence of improved outcomes in middle-income countries. For others there is a long journey ahead.en_US
dc.identifier.otherdoi: 10.1111/bjh.14617.
dc.identifier.otherVol.177(6)
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/32007
dc.language.isoenen_US
dc.publisherBritish Journal of Haematologyen_US
dc.subjectCancersen_US
dc.subjectChildhooden_US
dc.subjectLowen_US
dc.subjectMiddle-Incomeen_US
dc.subjectProgressen_US
dc.subjectSettingsen_US
dc.titleHaematological Cancers in African Children: Progress and Challengesen_US
dc.typeArticleen_US

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Child Health